For its Sterile injectable site near Gummidopoondi
Caplin Point Laboratories announced that US FDA inspection is to be conducted for the Company Sterile injectable site located near Gummidopoondi in third week of October. This Prior Approval Inspection(PAI) is in relation to an Injectable product ANDA being submitted with US FDA.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
